3,641 Shares in Globe Life Inc. $GL Purchased by Man Group plc

Man Group plc acquired a new stake in Globe Life Inc. (NYSE:GL) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,641 shares of the company’s stock, valued at approximately $651,000.

Several other hedge funds also recently bought and sold shares of GL. BlackRock Inc. acquired a new stake in shares of Globe Life during the second quarter valued at about $987,901,000. Invesco Ltd. increased its holdings in Globe Life by 2.7% in the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after purchasing an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in Globe Life by 10.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after purchasing an additional 217,331 shares during the last quarter. Morgan Stanley raised its position in Globe Life by 7.2% in the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after purchasing an additional 125,567 shares during the period. Finally, Arrowstreet Capital Limited Partnership raised its position in Globe Life by 32.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after purchasing an additional 355,399 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Weiss Ratings lowered Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. Jefferies Financial Group lifted their target price on Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a research report on Friday, July 10th. Morgan Stanley increased their price target on shares of Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a research report on Monday, July 6th. JPMorgan Chase & Co. increased their price target on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Finally, Piper Sandler lifted their price objective on shares of Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $191.67.

Insider Transactions at Globe Life

In other Globe Life news, CEO Frank Svoboda sold 10,000 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $166.68, for a total value of $1,666,800.00. Following the sale, the chief executive officer directly owned 54,020 shares in the company, valued at $9,004,053.60. This trade represents a 15.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Thomas Kalmbach sold 25,650 shares of Globe Life stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total value of $4,580,577.00. Following the sale, the chief financial officer directly owned 50,568 shares of the company’s stock, valued at $9,030,433.44. This trade represents a 33.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 151,908 shares of company stock valued at $27,239,981 over the last ninety days. Company insiders own 2.11% of the company’s stock.

Globe Life Stock Performance

Shares of Globe Life stock opened at $176.34 on Friday. The business has a 50-day simple moving average of $178.65 and a 200-day simple moving average of $160.50. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a one year low of $127.85 and a one year high of $191.55. The company has a market cap of $13.55 billion, a PE ratio of 11.71 and a beta of 0.46.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The firm had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the prior year, the firm earned $3.05 EPS. The firm’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities research analysts forecast that Globe Life Inc. will post 15.71 EPS for the current fiscal year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio is 8.76%.

Globe Life declared that its Board of Directors has initiated a share buyback plan on Monday, August 10th that allows the company to repurchase $2.50 billion in shares. This repurchase authorization allows the company to repurchase up to 17.7% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company’s leadership believes its stock is undervalued.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.